Catalyst Wire Dossier Catalyst Wire Dossier

Crenolanib

Crenolanib · Arog Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

15 regulatory and trial events tracked for Crenolanib, covering 2017-04-26 to 2026-04-09. Get the full timeline:

Most recent: Clinical Trial Update: Study of Crenolanib vs Midostaurin Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed FLT3 Mutated AML [Phase 3]

See pricing